- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01611454
New Fabric Attenuation Device in Endovascular Interventional Radiology II (PREFER II) (PREFER-II)
Prospective Randomized Evaluation of a New Fabric Attenuation Device in Endovascular Interventional Radiology II (PREFER II)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The PREFER II trial has three main objectives. The primary objective of the trial is to show how much radiation attenuation is provided by XPF thyroid collars in absolute and relative terms. The secondary objective of the study is to measure and compare the amount of radiation that interventional radiologists are exposed to per case in an interventional suite setting using FDA approved XPF thyroid collars or standard 0.5 mm Pb equivalent thyroid collars.
The third objective is to assess the operator comfort wearing the XPF protection devices. In order to achieve these objectives, measurements will be performed in 150 consecutive interventional procedures requiring C-arm fluoroscopy performed at BCVI. A prospective randomization will be performed, assigning participants to wear their own standard 0.5 mm Pb equivalent thyroid collar or to wear the FDA approved XPF thyroid collar. Radiation exposure will be monitored with 2 radiation detectors (TLDs, one inside and one outside the thyroid collar) which the participant is required to wear. After each procedure the participant will be asked to rate the comfort of wearing the devices on a scale from 1 to 100.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33176
- Baptist Hospital of Miami, Baptist Cardiac and Vascular Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Interventional Radiologists practicing in Baptist Cardiac & Vascular Institute
- consecutive endovascular procedure requiring C-arm fluoroscopy
Exclusion Criteria:
- Interventional Neuroradiologists and Interventional Cardiologists will not be included in this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: XPF thyroid collar
Administration of the XPF Thyroid Collar during the same type of interventional radiology procedures as Comparator arm above
|
Interventionalist wear the experimental (XPF) thyroid collar during fluoroscopy guided interventions.
|
Active Comparator: Equivalent collar
Administration of the Standard 0.5mm lead-equivalent thyroid collar during the same type of interventional radiology procedures as Comparator arm above.
|
Interventionalist wear a standard 0.5mm lead equivalent thyroid collar during the same type of comparator fluoroscopy guided interventions.
Comparator arm uses same type of lead thyroid collar but the XPF under investigation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage Change
Time Frame: 1 day
|
Radiation attenuation.
The null hypothesis is that the XPF thyroid collar is equal to the standard 0.5mm Pb lead equivalent thyroid collar with regard to radiation attenuation/transmission in relative (%) terms.
The alternative hypothesis is that the XPF thyroid collar is superior or inferior to the standard thyroid collar.
Based on our results obtained during the 60 procedures (PREFER trial), 150 procedures are required to demonstrate a significant difference with an alpha level of 5% and a power of 80%.
Radiation attenuation percentage is measure by interrogation of the lead attenuates X-rays counter required to be used in all interventional radiology clinical procedures by each physician operator.
The interrogation is done by measuring the energy imparted per unit mass in the counter wore by ionizing radiation to matter at the specified point.
The International System of Units (SI) unit of absorbed dose is the joule per kilogram.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wearing Comfort of the Collar on a Scale From 0-100.
Time Frame: 1 day
|
Operators are asked directly after each procedure to rate the wearing comfort, graded worst to best.
0 means low comfort (worse outcome) and 100 is the best comfort level (best outcome) with wearing the collar.
|
1 day
|
Radiation Exposure (uSv) for for Both the Thyroid and Equivalent Collars
Time Frame: 1 day
|
(day 1) Operators are asked directly after each procedure to rate the wearing comfort Radiation exposure will be monitored with radiation detectors (TLDs, 2 attached to the collar) which the participant is required to wear.
Exposure is measured as the energy imparted per unit mass by ionizing radiation to the matter at the specified time of the procedure.
The International System of Units (SI) unit of absorbed dose is the joule per kilogram.
The special name for this unit is the gray (Gy).
For purposes of radiation protection and assessing dose or risk to humans in general terms, the quantity normally calculated is the mean absorbed dose in an organ or tissue.
|
1 day
|
Radiation Exposure (uSv) for XPF Caps and the Equivalent Caps
Time Frame: 1 day
|
(day 1) Operators are asked directly after each procedure to rate the wearing comfort Radiation exposure will be monitored with radiation detectors, which the participant is required to wear.
Exposure is measured as the energy imparted per unit mass by ionizing radiation to the matter at the specified time of the procedure.
The International System of Units (SI) unit of absorbed dose is the joule per kilogram.
The special name for this unit is the gray (Gy).
For purposes of radiation protection and assessing dose or risk to humans in general terms, the quantity normally calculated is the mean absorbed dose in an organ or tissue.
|
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Barry T Katzen, MD, Baptist Hospital of Miami, Baptist Cardiac and Vascular Institute
- Principal Investigator: Heiko Uthoff, MD, Baptist Hospital of Miami, Baptist Cardiac and Vascular Institute
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PREFER II
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Occupational Exposure to Radiation
-
Instituto de Cardiologia do Rio Grande do SulCompletedRadiation Injury | Exposure to Ionizing Radiation | Occupational Exposure to RadiationBrazil
-
Baptist Health South FloridaCompletedOccupational Exposure to RadiationUnited States
-
Korea Institute of Radiological & Medical SciencesActive, not recruitingRadiation Effects | Neoplasms, Radiation-Induced | Occupational Exposure to Radiation | Leukemia, Radiation-InducedKorea, Republic of
-
J.P.S HenriquesCompletedRadiation; Exposure Occupational | Coronary InterventionsNetherlands
-
Total Cardiovascular SolutionsCompletedExposure to Ionizing RadiationIndia
-
University Hospital, Strasbourg, FranceRecruitingExposure to Chemical Pollution, OccupationalFrance
-
Royal Marsden NHS Foundation TrustCompletedExposure to Medical Diagnostic RadiationUnited Kingdom
-
Seoul National University HospitalUnknownExposure to Medical Diagnostic RadiationKorea, Republic of
-
Environmental Protection Agency (EPA)CompletedExposure to Environmental Pollution, Non-occupationalUnited States
-
Environmental Protection Agency (EPA)CompletedExposure to Environmental Pollution, Non-occupationalUnited States
Clinical Trials on XPF thyroid collar
-
Xenon Pharmaceuticals Inc.CompletedHealthy Human VolunteersCanada
-
Xenon Pharmaceuticals Inc.CompletedPostherpetic NeuralgiaUnited States
-
Xenon Pharmaceuticals Inc.CompletedDental PainUnited States
-
Brigham and Women's HospitalMassachusetts General Hospital; Beth Israel Deaconess Medical CenterTerminatedCervical Spondylosis Symptomatic Neurological CompressionUnited States
-
Xenon Pharmaceuticals Inc.Completed
-
Oslo University HospitalTerminatedCollar Treatment of Stable Subaxial Spine FracturesNorway
-
Region SkaneJRI Orthopaedics LtdActive, not recruitingHip Replacement in Osteoarthritis PatientsSweden
-
Haukeland University HospitalUnknown